BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23534495)

  • 1. Effective parameters in determining cross-linked dextran microsphere characteristics: screening by Plackett-Burman design-of-experiments.
    Kenari HS; Alinejad Z; Imani M; Nodehi A
    J Microencapsul; 2013; 30(6):599-611. PubMed ID: 23534495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of dextran crosslinking by epichlorohydrin: a rheometry and equilibrium swelling study.
    Emami Meybodi Z; Imani M; Atai M
    Carbohydr Polym; 2013 Feb; 92(2):1792-8. PubMed ID: 23399221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteric-coated epichlorohydrin crosslinked dextran microspheres for site-specific delivery to colon.
    Rai G; Yadav AK; Jain NK; Agrawal GP
    Drug Dev Ind Pharm; 2015; 41(12):2018-28. PubMed ID: 26006331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An engineering approach to design of dextran microgels size fabricated by water/oil emulsification.
    Salimi-Kenari H; Imani M; Nodehi A; Abedini H
    J Microencapsul; 2016 Sep; 33(6):511-523. PubMed ID: 27686531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of epichlorohydrin cross-linked starch microspheres.
    Hamdi G; Ponchel G; Duchêne D
    J Microencapsul; 2001; 18(3):373-83. PubMed ID: 11308227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.
    Mao S; Xu J; Cai C; Germershaus O; Schaper A; Kissel T
    Int J Pharm; 2007 Apr; 334(1-2):137-48. PubMed ID: 17196348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of water-soluble drugs in PLGA microspheres.
    Ito F; Fujimori H; Makino K
    Colloids Surf B Biointerfaces; 2007 Feb; 54(2):173-8. PubMed ID: 17137764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release characteristics of salmon calcitonin from dextran hydrogels for colon-specific delivery.
    Basan H; Gümüşderelioğlu M; Tevfik Orbey M
    Eur J Pharm Biopharm; 2007 Jan; 65(1):39-46. PubMed ID: 16950607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.
    Kang J; Wu F; Cai Y; Xu M; He M; Yuan W
    Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The preparation of dextran microspheres in an all-aqueous system: effect of the formulation parameters on particle characteristics.
    Stenekes RJ; Franssen O; van Bommel EM; Crommelin DJ; Hennink WE
    Pharm Res; 1998 Apr; 15(4):557-61. PubMed ID: 9587951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of a new type of porous starch microspheres (PSM) and effect of physicochemical properties on water uptake rate.
    Zhu J; Sun W; Meng Z; Zhu X; Gan H; Gu R; Wu Z; Dou G
    Int J Biol Macromol; 2018 Sep; 116():707-714. PubMed ID: 29763704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microparticles based on natural and synthetic polymers for ophthalmic applications.
    Tataru G; Popa M; Costin D; Desbrieres J
    J Biomed Mater Res A; 2012 May; 100(5):1209-20. PubMed ID: 22344747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, Optimization, and Evaluation of Epichlorohydrin Cross-Linked Enset (
    Tesfay D; Abrha S; Yilma Z; Woldu G; Molla F
    Biomed Res Int; 2020; 2020():2147971. PubMed ID: 32337231
    [No Abstract]   [Full Text] [Related]  

  • 14. Preparing polymer-based sustained-release systems without exposing proteins to water-oil or water-air interfaces and cross-linking reagents.
    Jin T; Zhu J; Wu F; Yuan W; Geng LL; Zhu H
    J Control Release; 2008 May; 128(1):50-9. PubMed ID: 18417240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles.
    Chalasani KB; Russell-Jones GJ; Jain AK; Diwan PV; Jain SK
    J Control Release; 2007 Sep; 122(2):141-50. PubMed ID: 17707540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
    Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Optimization and property evaluation of gelatin microspheres for embolization].
    Wu YN; Cui DC; Liu YY; Fan TY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Jun; 44(3):464-8. PubMed ID: 22692322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug.
    Wang LY; Ma GH; Su ZG
    J Control Release; 2005 Aug; 106(1-2):62-75. PubMed ID: 15922472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of alginate microspheres produced using emulsification technique.
    Heng PW; Chan LW; Wong TW
    J Microencapsul; 2003; 20(3):401-13. PubMed ID: 12881119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation and biological characteristics of a new doxorubicin-gelatin-microspheres for hepatic artery embolization].
    Wan Y; Ma Y; Chen XL; Duan LG; Luo DH; Xia CQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):119-24. PubMed ID: 21355316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.